Reason for request
Re-assessment of the Actual Benefit
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicinal product ROHYPNOL is insufficient in the treatment of "severe sleep disorders in the following cases: occasional insomnia, transient insomnia". |
Therapeutic use
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
TCSbcDhS9vd1ALTG
